NY settlement highlights risks, costs of Indivior’s overdose drug

NY settlement highlights risks, costs of Indivior’s overdose drug

The pharmaceutical manufacturer Indivior has stopped marketing Opvee, its controversial overdose-reversal medication, after two years of meager sales, outcry from harm reduction groups, and intense scrutiny from New York State’s top law enforcement official.  On Tuesday, New York Attorney General Letitia James unveiled a settlement with Indivior that she said would result in the company…

Read More